[
    [
        {
            "time": "2020-06-10",
            "original_text": "每日全球并购：杉杉股份拟7.7亿美元收购LG化学旗下业务，国航25亿港元收购国泰航空股份",
            "features": {
                "keywords": [
                    "杉杉股份",
                    "LG化学",
                    "并购",
                    "国航",
                    "国泰航空"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工",
                    "航空"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "每日全球并购：杉杉股份拟7.7亿美元收购LG化学旗下业务，国航25亿港元收购国泰航空股份",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "聚焦行业，内外联动，扬帆全球——华泰国际打造境外投资银行旗舰",
            "features": {
                "keywords": [
                    "华泰国际",
                    "境外投资",
                    "旗舰"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "聚焦行业，内外联动，扬帆全球——华泰国际打造境外投资银行旗舰",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "抗菌药将被作为重点纳入处方审核 华熙生物拟2.9亿元收购佛思特生物 | 医资日报",
            "features": {
                "keywords": [
                    "抗菌药",
                    "华熙生物",
                    "佛思特生物",
                    "收购"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "抗菌药将被作为重点纳入处方审核 华熙生物拟2.9亿元收购佛思特生物 | 医资日报",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "上市不满一年就并购扩张 华熙生物拟2.9亿购入行业老四",
            "features": {
                "keywords": [
                    "华熙生物",
                    "并购",
                    "扩张"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市不满一年就并购扩张 华熙生物拟2.9亿购入行业老四",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华熙生物“捡便宜”？2.9亿元收购佛思特生物 透明质酸钠产能将超400吨/年",
            "features": {
                "keywords": [
                    "华熙生物",
                    "佛思特生物",
                    "透明质酸钠",
                    "产能"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物“捡便宜”？2.9亿元收购佛思特生物 透明质酸钠产能将超400吨/年",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)：收购玻尿酸原料商佛思特 开启行业整合强化龙头地位",
            "features": {
                "keywords": [
                    "华熙生物",
                    "玻尿酸",
                    "佛思特",
                    "行业整合"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)：收购玻尿酸原料商佛思特 开启行业整合强化龙头地位",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物收购佛思特生物 剑指全球玻尿酸半壁江山",
            "features": {
                "keywords": [
                    "华熙生物",
                    "佛思特生物",
                    "玻尿酸",
                    "市场占有率"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物收购佛思特生物 剑指全球玻尿酸半壁江山",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)事件点评：收购佛思特生物 公司原料产能更上层楼",
            "features": {
                "keywords": [
                    "华熙生物",
                    "佛思特生物",
                    "原料产能"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)事件点评：收购佛思特生物 公司原料产能更上层楼",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "中信证券：预计国庆前绝大部分消费领域将恢复至疫情前",
            "features": {
                "keywords": [
                    "中信证券",
                    "消费领域",
                    "疫情",
                    "恢复"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中信证券：预计国庆前绝大部分消费领域将恢复至疫情前",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华熙生物拿下佛思特 透明质酸头部企业整合提速",
            "features": {
                "keywords": [
                    "华熙生物",
                    "佛思特",
                    "透明质酸",
                    "整合"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物拿下佛思特 透明质酸头部企业整合提速",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "东辰集团重整计划获裁定通过 华熙生物购佛思特扩充玻尿酸产能 减资破产",
            "features": {
                "keywords": [
                    "东辰集团",
                    "重整",
                    "华熙生物",
                    "佛思特",
                    "玻尿酸",
                    "产能",
                    "减资破产"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东辰集团重整计划获裁定通过 华熙生物购佛思特扩充玻尿酸产能 减资破产",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]